Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

KSK Diagnostics

KSK Diagnostics
Out of Business LATEST DEAL TYPE

Developer of molecular point-of-care diagnostic assays designed to diagnose infectious diseases and cancer. The company's assays use isothermal amplification technology for patient-oriented diagnostics and are also suited to quickly clarify issues related to tumour diagnostics, enabling doctors to make a diagnosis after 30 minutes and coordinate the treatment.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
  • Tempowerkring 1
  • 21079 Hamburg
  • Germany

+49 040 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KSK Diagnostics’s full profile, request a free trial.

KSK Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2019 Completed Out of Business
2. Early Stage VC (Series A) 24-Apr-2017 Completed Startup
1. Grant $164K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

KSK Diagnostics Executive Team (3)

Name Title Board
Stefan Kulick Co-Founder & Managing Director
Guido Krupp Co-Founder
Peter Scheinert Co-Founder